Ousted CytoDyn CEO Pourhassan Sentenced To 30 Months For Securities Fraud

Company Near The End Of Its Cash Runway

The DOJ said Pourhassan was sentenced on Jan. 23 following his conviction in late 2024 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Legal & IP

More from Business